Abstract:Nonsevere obstructive sleep apnea (OSA) is most often treated with a continuous positive airway pressure (CPAP) device or a mandibular advancement splint (MAS). However, patient compliance with these treatments is difficult to predict. Improvement in apnea-hypopnea index (AHI) is also somewhat unpredictable in MAS treatment. In this study, we investigated the association between Friedman tongue position score (Friedman score) and both treatment compliance and AHI improvement in patients with nonsevere OSA rece… Show more
“…Objective measures of PAP compliance have recently become part of routine clinical practice, and insurance companies now cover reimbursements for the devices and disposable supplies according to the compliance measured by the PAP device itself (Hevener & Hevener, 2016). In contrast, measurement of compliance to OA therapy has relied on self‐reporting in many studies (Berg et al, 2020; Lo et al, 2021; Pahkala & Suominen, 2021) as well as in routine clinical practice. Lowe et al first presented objective evidence of compliance using a monitor with a temperature sensor (Lowe et al, 2000), and additional studies have since reported objective compliance with OA.…”
Section: Discussionmentioning
confidence: 99%
“…Objective measures of PAP compliance have recently become part of routine clinical practice, and insurance companies now cover reimbursements for the devices and disposable supplies according to the compliance measured by the PAP device itself (Hevener & Hevener, 2016). In contrast, measurement of compliance to OA therapy has relied on self-reporting in many studies (Berg et al, 2020 and micro-recorder (DentiTrac ® ; Braebon Medical). In this study, a micro-recorder (DentiTrac ® ) embedded into an OA was used to monitor objective compliance with the OA.…”
Summary
Compliance with a mandibular advancement device is important for the optimal treatment of obstructive sleep apnea. Recent advances in information and communication technology‐based monitoring and intervention for chronic diseases have enabled continuous monitoring and personalized management. Self‐evaluation and self‐regulation through objective monitoring and feedback may improve compliance. The aim of this study was to evaluate the effects of information and communication technology‐based remote monitoring and feedback services, using a smartphone application, on the objective compliance with a mandibular advancement device in patients with obstructive sleep apnea. Forty individuals who were diagnosed with obstructive sleep apnea by polysomnography were randomly assigned to groups A and B. During an initial 6‐week evaluation period, the mandibular advancement device‐wearing time was monitored with the smartphone application in group B, but not in group A. The two groups then switched the monitoring procedures during the second 6‐week period (the smartphone application was then used by group B, but not by group A). If no input data were indicated on the cloud server of the smartphone application during the monitored period, push notifications were provided twice daily. Objective compliance, monitored by a micro‐recorder within the mandibular advancement device, was noted and compared based on whether the monitoring service was provided. The number of mandibular advancement device‐wearing days was significantly higher in the monitored period than in the unmonitored period. The mandibular advancement device‐wearing time did not differ significantly between the two groups. In conclusion, information and communication technology‐based remote monitoring and feedback services demonstrated a potential to increase the objective measures of compliance with mandibular advancement devices.
“…Objective measures of PAP compliance have recently become part of routine clinical practice, and insurance companies now cover reimbursements for the devices and disposable supplies according to the compliance measured by the PAP device itself (Hevener & Hevener, 2016). In contrast, measurement of compliance to OA therapy has relied on self‐reporting in many studies (Berg et al, 2020; Lo et al, 2021; Pahkala & Suominen, 2021) as well as in routine clinical practice. Lowe et al first presented objective evidence of compliance using a monitor with a temperature sensor (Lowe et al, 2000), and additional studies have since reported objective compliance with OA.…”
Section: Discussionmentioning
confidence: 99%
“…Objective measures of PAP compliance have recently become part of routine clinical practice, and insurance companies now cover reimbursements for the devices and disposable supplies according to the compliance measured by the PAP device itself (Hevener & Hevener, 2016). In contrast, measurement of compliance to OA therapy has relied on self-reporting in many studies (Berg et al, 2020 and micro-recorder (DentiTrac ® ; Braebon Medical). In this study, a micro-recorder (DentiTrac ® ) embedded into an OA was used to monitor objective compliance with the OA.…”
Summary
Compliance with a mandibular advancement device is important for the optimal treatment of obstructive sleep apnea. Recent advances in information and communication technology‐based monitoring and intervention for chronic diseases have enabled continuous monitoring and personalized management. Self‐evaluation and self‐regulation through objective monitoring and feedback may improve compliance. The aim of this study was to evaluate the effects of information and communication technology‐based remote monitoring and feedback services, using a smartphone application, on the objective compliance with a mandibular advancement device in patients with obstructive sleep apnea. Forty individuals who were diagnosed with obstructive sleep apnea by polysomnography were randomly assigned to groups A and B. During an initial 6‐week evaluation period, the mandibular advancement device‐wearing time was monitored with the smartphone application in group B, but not in group A. The two groups then switched the monitoring procedures during the second 6‐week period (the smartphone application was then used by group B, but not by group A). If no input data were indicated on the cloud server of the smartphone application during the monitored period, push notifications were provided twice daily. Objective compliance, monitored by a micro‐recorder within the mandibular advancement device, was noted and compared based on whether the monitoring service was provided. The number of mandibular advancement device‐wearing days was significantly higher in the monitored period than in the unmonitored period. The mandibular advancement device‐wearing time did not differ significantly between the two groups. In conclusion, information and communication technology‐based remote monitoring and feedback services demonstrated a potential to increase the objective measures of compliance with mandibular advancement devices.
“…Participants aged ≥ 18 years who were referred to our units for sleep respiratory disorders were enrolled and subjected to clinical diagnostic evaluation and consequently phenotyped. A full clinical history of symptoms, such as morning headache and decreased libido, validated questionnaires (ESS), and anatomical or endoscopic scores were collected ( Table 1 ) ( Supplementary File S1–S3 ) [ 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 ].…”
Objectives: To evaluate the role of clinical scores assessing the risk of disease severity in patients with clinical suspicion of obstructive sleep apnea syndrome (OSA). The hypothesis was tested by applying artificial intelligence (AI) to demonstrate its effectiveness in distinguishing between mild–moderate OSA and severe OSA risk. Methods: A support vector machine model (SVM) was developed from the samples included in the analysis (N = 498), and they were split into 75% for training (N = 373) with the remaining for testing (N = 125). Two diagnostic thresholds were selected for OSA severity: mild to moderate (apnea–hypopnea index (AHI) ≥ 5 events/h and AHI < 30 events/h) and severe (AHI ≥ 30 events/h). The algorithms were trained and tested to predict OSA patient severity. Results: The sensitivity and specificity for the SVM model were 0.93 and 0.80 with an accuracy of 0.86; instead, the logistic regression full mode reported a value of 0.74 and 0.63, respectively, with an accuracy of 0.68. After backward stepwise elimination for features selection, the reduced logistic regression model demonstrated a sensitivity and specificity of 0.79 and 0.56, respectively, and an accuracy of 0.67. Conclusion: Artificial intelligence could be applied to patients with symptoms related to OSA to identify individuals with a severe OSA risk with clinical-based algorithms in the OSA framework.
“…Drug-induced sleep endoscopy was performed for all the patients. All patients revealed vellum anterior–posterior collapse over 50% and oropharyngeal lateral 50% collapse, reaching the Friedman grade II of lingual tonsils hypertrophy without epiglottic collapse by drug-induced sleep endoscopy (DISE) under the VOTE grading system [ 20 ]. In addition, all patients underwent PSG, which revealed at least moderate and severe OSA.…”
Background: Successful surgery outcomes are limited to moderate to severe obstructive sleep apnea (OSA) syndrome. Multilevel collapse at retropalatal and retroglossal areas is often found during the drug-induced sleep endoscopy (DISE). Therefore, multilevel surgery is considered for these patients. The aim of our study was to survey surgical outcomes by modified uvulopalatoplasty (UPPP) plus transoral robotic surgery tongue base reduction (TORSTBR) versus barbed repositioning pharyngoplasty (BRP) plus TORSTBR. Methods: The retrospective cohort study was performed at a tertiary referral center. We collected moderate to severe OSA patients who were not tolerant to positive pressure assistant PAP from September 2016 to September 2019; pre-operative–operative Muller tests all showed retropalatal and retroglossal collapse; pre-operative Friedman Tongue Position (FTP) > III, with the tonsils grade at grade II minimum, with simultaneous velum (V > 1) and tongue base (T > 1), collapsed by drug-induced sleep endoscopy (DISE) under the VOTE grading system. The UPPP plus TORSTBR (n = 31) and BRP plus TORSTBR (n = 31) techniques were offered. We compare the outcomes using an Epworth sleepiness scale (ESS) questionnaire, and measure the patients’ apnea–hypopnea index (AHI), lowest O2 saturation, cumulative time spent below 90% (CT90), and arousal index (AI) by polysomnography six months after surgery; we also measure their length of hospital stay and complications between these two groups. Results: Comparing BRP plus TORSTBR with UPPP plus TORSTBR, the surgical success rate is 67.74% and 38.71%, respectively. The significantly higher surgical success rate in the BRP plus TORSTBR group was noted. The surgical time is shorter in the BRP plus TORSTBR group. The complication rate is not significant in pain, bleeding, dysgeusia, dysphagia, globus sensation, and prolonged suture stay, even though the BRP plus TORSTBR rendered a higher percentage of globus sensation during swallowing and a more prevalent requirement of suture removal one month after surgery. The length of hospital stay is not significantly different between the two groups. Conclusion: In conclusion, BRP plus TORSTBR is a considerable therapy for moderate to severe OSA patients with DISE showing a multi-level collapse in velum and tongue base area. The BRP technique might offer a better anterior–posterior suspension vector for palate level obstruction.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.